Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of diabetes after para-aortic radiation for testicular cancer.
Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de Wit R, Witjes JA, Groenewegen G, de Brouwer P, Meijer OWM, Hulshof MCCM, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, van den Bergh ACM, Kerst JM, van den Belt-Dusebout AW, Lubberts S, Jóźwiak K, Horenblas S, van Leeuwen FE, Schaapveld M. Groot HJ, et al. Among authors: incrocci l. Br J Cancer. 2018 Oct;119(7):901-907. doi: 10.1038/s41416-018-0248-x. Epub 2018 Oct 9. Br J Cancer. 2018. PMID: 30297773 Free PMC article.
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.
Groot HJ, Lubberts S, de Wit R, Witjes JA, Kerst JM, de Jong IJ, Groenewegen G, van den Eertwegh AJM, Poortmans PM, Klümpen HJ, van den Berg HA, Smilde TJ, Vanneste BGL, Aarts MJ, Incrocci L, van den Bergh ACM, Jóźwiak K, van den Belt-Dusebout AW, Horenblas S, Gietema JA, van Leeuwen FE, Schaapveld M. Groot HJ, et al. Among authors: incrocci l. J Clin Oncol. 2018 Aug 20;36(24):2504-2513. doi: 10.1200/JCO.2017.77.4174. Epub 2018 Jul 10. J Clin Oncol. 2018. PMID: 29989856
Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial.
de Vries KC, Wortel RC, Oomen-de Hoop E, Heemsbergen WD, Pos FJ, Incrocci L. de Vries KC, et al. Among authors: incrocci l. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):108-115. doi: 10.1016/j.ijrobp.2019.09.007. Epub 2019 Oct 5. Int J Radiat Oncol Biol Phys. 2020. PMID: 31593756 Clinical Trial.
Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study.
Jahreiß MC, Heemsbergen WD, van Santvoort B, Hoogeman M, Dirkx M, Pos FJ, Janssen T, Dekker A, Vanneste B, Minken A, Hoekstra C, Smeenk RJ, van Oort IM, Bangma CH, Incrocci L, Aben KKH. Jahreiß MC, et al. Among authors: incrocci l. Front Oncol. 2021 Nov 26;11:771956. doi: 10.3389/fonc.2021.771956. eCollection 2021. Front Oncol. 2021. PMID: 34900722 Free PMC article.
Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands.
Deukeren DV, Heesterman BL, Roelofs L, Kiemeney LA, Witjes JA, Smilde TJ, Leenders GJLHV, Incrocci L, Vanneste BGL, Meijer RP, Siesling S, Bezooijen BPJV, Aben KKH; COVID and Cancer-NL consortium. Deukeren DV, et al. Among authors: incrocci l. Cancer Treat Res Commun. 2022;31:100553. doi: 10.1016/j.ctarc.2022.100553. Epub 2022 Apr 2. Cancer Treat Res Commun. 2022. PMID: 35421819 Free PMC article.
Advances in radiotherapy and its impact on second primary cancer risk: A multi-center cohort study in prostate cancer patients.
Jahreiß MC, Hoogeman M, Aben KK, Dirkx M, Snieders R, Pos FJ, Janssen T, Dekker A, Vanneste B, Minken A, Hoekstra C, Smeenk RJ, Incrocci L, Heemsbergen WD. Jahreiß MC, et al. Among authors: incrocci l. Radiother Oncol. 2023 Jun;183:109659. doi: 10.1016/j.radonc.2023.109659. Epub 2023 Mar 30. Radiother Oncol. 2023. PMID: 37003369 Free article.
149 results